Literature DB >> 4214764

IgG heavy chain sub-classes in mixed cryoglobulins.

J J Cream, A Howard, G Virella.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4214764      PMCID： PMC1407928     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  24 in total

1.  Characterization of a human macroglobulin. V. A Waldenström macroglobulin with antibody activity.

Authors:  H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

2.  Specificity of human anti-gamma-globulin factors for heavy chain subgroup determinants and autologous gamma-globulin fragments.

Authors:  J B Natvig
Journal:  Bibl Haematol       Date:  1968

3.  On the nature of cryoglobulins.

Authors:  H H Zinneman; D Levi; U S Seal
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

4.  Serological heterogeneity of the IgM components of mixed (monoclonal IgM-polyclonal IgG) cryoglobulins.

Authors:  M R Mackenzie; L S Goldberg; E V Barnett; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

5.  In vivo study of IgM rheumatoid factors from mixed cryoglobulins.

Authors:  E M Caperton; R C Williams
Journal:  J Lab Clin Med       Date:  1969-08

6.  IgM-IgG cryoglobulinaemia with IgM paraprotein component.

Authors:  F Klein; J J van Rood; R van Furth; H Radema
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

7.  Coprecipitation of some cryomacroglobulins with immunoglobulins and their fragments.

Authors:  C C Curtain; A Baumgarten; J Pye
Journal:  Arch Biochem Biophys       Date:  1965-10       Impact factor: 4.013

8.  Myeloma proteins and antibodies.

Authors:  H Metzger
Journal:  Am J Med       Date:  1969-12       Impact factor: 4.965

9.  Anti-heavy chain activity of the monoclonal (paraprotein) cryoglobulins with rheumatoid factor effect.

Authors:  V Balázs; M M Fröhlich
Journal:  Am J Med Sci       Date:  1966-12       Impact factor: 2.378

10.  Human monoclonal gamma G-cryoglobulins with anti-gamma-globulin activity.

Authors:  H M Grey; P F Kohler; W D Terry; E C Franklin
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808
View more
  8 in total

1.  Antiviral antibodies in rheumatoid synovial fluid and cryoprecipitates.

Authors:  N E Cremer; D Hurwitz; F P Quismorio; E H Lennette; G J Friou
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

2.  Serum complement pattern in essential mixed cryoglobulinaemia.

Authors:  A Tarantino; A Anelli; A Costantino; A De Vecchi; G Monti; L Massaro
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

3.  Studies of human IgM anti-IgG cryoglobulins: II. Isoelectric focusing characteristics of the reactive antigen and residual serum IgG pools.

Authors:  S L Johnston; J R Jorizzo; D F Liberman; G N Abraham
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

4.  Studies of human anti-IgM anti-IgG cryoglobulins. I. Patterns of reactivity with autologous and isologous human IgG and its subunits.

Authors:  S L Johnston; G N Abraham
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  IgG rheumatoid factors and cryoglobulins in mice bearing the mutant gene lpr (lymphoproliferation).

Authors:  S Izui; M Abdelmoula; Y Gyotoku; G Lange; P H Lambert
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates.

Authors:  J A Schifferli; N Amos; C D Pusey; J G Sissons; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 7.  Clearance of cryoglobulins in man.

Authors:  Y C Ng; J A Schifferli
Journal:  Springer Semin Immunopathol       Date:  1988

8.  IgG subclasses in cryoglobulins: link to composition and clinical manifestations.

Authors:  Marie N Kolopp-Sarda; Pedro Ming Azevedo; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2020-11-12       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.